Company profile

Ticker
PHR
Exchange
CEO
Chaim Indig
Employees
Incorporated in
Location
Fiscal year end
Former names
Phreesia Inc
SEC CIK

PHR stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

9 Jun 20
9 Jul 20
31 Jan 21

News

Company financial data Financial data

Quarter (USD) Apr 20 Jan 20 Oct 19 Jul 19
Revenue 33.4M 32.82M 32.84M 30.82M
Net income -6.11M -3.67M -2.44M -7.49M
Diluted EPS -0.16 -0.1 -0.07 -1.1
Net profit margin -18.30% -11.18% -7.42% -24.32%
Operating income -4.97M -4.67M -2.23M -4.14M
Net change in cash -63K -1.07M -8.66M 94.14M
Cash on hand 90.25M 90.32M 91.39M 100.05M
Annual (USD) Jan 20 Jan 19 Jan 18
Revenue 124.78M 99.89M 79.83M
Net income -20.29M -15.06M -18.19M
Diluted EPS -4.5 -24.53 -24.81
Net profit margin -16.26% -15.08% -22.79%
Operating income -15.3M -9.49M -14.55M
Net change in cash 88.77M -8.96M
Cash on hand 90.32M 1.54M 10.5M

Financial data from Phreesia earnings reports

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
1 Jul 20 Linetsky David Common Stock Sell Dispose S Yes 28.2449 4,475 126.4K 131,177
1 Jul 20 Linetsky David Common Stock Option exercise Aquire M Yes 4.71 1,376 6.48K 135,652
1 Jul 20 Linetsky David Stock Option Common Stock Option exercise Dispose M Yes 4.71 1,376 6.48K 20,003
1 Jul 20 Roberts Evan Common Stock Sell Dispose S Yes 28.4498 12,500 355.62K 701,299
17 Jun 20 Kallenbach Charles Common Stock Sell Dispose S Yes 29.2581 2,500 73.15K 39,150
17 Jun 20 Kallenbach Charles Common Stock Option exercise Aquire M Yes 2.55 2,500 6.38K 41,650
17 Jun 20 Kallenbach Charles Stock Option Common Stock Option exercise Dispose M Yes 2.55 2,500 6.38K 146,785
12 Jun 20 Munson Gillian Common Stock Sell Dispose S No 28.32 5,000 141.6K 16,048
11 Jun 20 Michael J. Davidoff Common Stock Option exercise Aquire M No 0.84 13,084 10.99K 124,087
11 Jun 20 Michael J. Davidoff Stock Option Common Stock Option exercise Dispose M No 0.84 13,084 10.99K 39,252
71.0% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 99 95 +4.2%
Opened positions 29 37 -21.6%
Closed positions 25 11 +127.3%
Increased positions 45 34 +32.4%
Reduced positions 17 20 -15.0%
13F shares
Current Prev Q Change
Total value 562.69M 626.53M -10.2%
Total shares 26.72M 23.52M +13.6%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
LLR Walnut 3.78M $79.44M 0.0%
BLK BlackRock 2.5M $52.48M +62.9%
FMR 2.26M $47.49M +11.5%
N Price T Rowe Associates 1.67M $35.03M +38.2%
Citadel Advisors 1.1M $23.17M +11.7%
Brown Advisory 1.08M $22.75M +10.1%
TimesSquare Capital Management 930.9K $19.58M -14.4%
Vanguard 848.61K $17.85M +10.2%
Loomis Sayles & Co L P 783.8K $16.48M +25.6%
Capital International Investors 768.5K $16.16M +92.1%
Largest transactions
Shares Bought/sold Change
BLK BlackRock 2.5M +964.06K +62.9%
Granite Investment Partners 528.42K +528.42K NEW
Clearbridge Advisors 0 -503.43K EXIT
N Price T Rowe Associates 1.67M +460.3K +38.2%
CS Credit Suisse 439.41K +431.1K +5185.8%
Tamarack Advisers 250K -410K -62.1%
GW&K Investment Management 385.75K +385.75K NEW
Capital International Investors 768.5K +368.5K +92.1%
STT State Street 498.8K +317.5K +175.1%
LH Capital Markets 0 -300K EXIT

Financial report summary

?
Risks
  • We have experienced net losses in the past and we may not achieve profitability in the future.
  • The healthcare industry is rapidly evolving and the market for technology-enabled services that empower healthcare consumers is relatively immature and unproven. If we are not successful in promoting the benefits of our Platform, our growth may be limited.
  • We have grown rapidly in recent periods, and if we fail to manage our growth effectively, our expenses could increase more than expected, our revenue may not increase and we may be unable to implement our business strategy.
  • We derive a significant portion of our revenues from our largest clients.
  • The growth of our business relies, in part, on the growth and success of our clients and certain revenues from our engagements, which are difficult to predict and are subject to factors outside of our control.
  • We may potentially compete with our partners, which may adversely affect our business.
  • If our existing clients do not continue to renew their contracts with us, renew at lower fee levels or decline to purchase additional applications and services from us, it could have a material adverse effect on our business, financial condition and results of operations.
  • Failure to adequately expand our direct sales force will impede our growth.
  • We typically incur significant upfront costs in our client relationships, and if we are unable to develop or grow these relationships over time, we are unlikely to recover these costs and our operating results may suffer.
  • If the estimates and assumptions we use to determine the size of our target market are inaccurate, our future growth rate may be impacted and our business would be harmed.
  • We are subject to data privacy and security laws and regulations governing our collection, use, disclosure, or storage of personally identifiable information, including personal health information and payment card data, which may impose restrictions on us and our operations and subject us to penalties if we are unable to fully comply with such laws.
  • Privacy concerns or security breaches relating to our Platform could result in economic loss, damage to our reputation, deterring users from using our products, and our exposure to legal penalties and liability.
  • If we are not able to maintain and enhance our reputation and brand recognition, our business and results of operations will be harmed.
  • Consolidation in the healthcare industry could have a material adverse effect on our business, financial condition and results of operations.
  • We may face intense competition, which could limit our ability to maintain or expand market share within our industry, and if we do not maintain or expand our market share our business and operating results will be harmed.
  • We are bound by exclusivity provisions that restrict our ability to enter into certain sales and marketing relationships in order to market and sell our services.
  • The healthcare regulatory and political framework is uncertain and evolving.
  • If we are unable to obtain, maintain and enforce intellectual property protection for our technology and products or if the scope of our intellectual property protection is not sufficiently broad, others may be able to develop and commercialize technology and products substantially similar to ours, and our ability to successfully commercialize our technology and products may be adversely affected.
  • If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our business may be adversely affected.
  • Third parties may initiate legal proceedings alleging that we are infringing or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on our business, financial condition and results of operations.
  • Our use of “open source” software could adversely affect our ability to offer our services and subject us to possible litigation.
  • If we are unable to protect the confidentiality of our trade secrets, know-how and other proprietary information, the value of our technology and products could be adversely affected.
  • We rely on our third-party vendors and partners to execute our business strategy. Replacing them would be difficult and disruptive to our business. If we are unsuccessful in forming or maintaining such relationships on terms favorable to us, our business may not succeed.
  • We rely on a limited number of third-party suppliers and contract manufacturers to support our products, and a loss or degradation in performance of these suppliers and contract manufacturers could have a negative effect on our business, financial condition and results of operations.
  • Any restrictions on our use of, or ability to license, data, or our failure to license data and integrate third-party technologies, could have a material adverse effect on our business, financial condition and results of operations.
  • If we cannot implement our solution for clients or resolve any technical issues in a timely manner, we may lose clients and our reputation may be harmed.
  • We rely on Internet infrastructure, bandwidth providers, data center providers, other third parties and our own systems for providing services to our clients, and any failure or interruption in the services provided by these third parties or our own systems could expose us to litigation and negatively impact our relationships with clients, adversely affecting our brand and our business.
  • We depend on our senior management team, and the loss of one or more of our executive officers or key employees or an inability to attract and retain highly skilled employees could adversely affect our business.
  • We may make future acquisitions and investments which may be difficult to integrate, divert management resources, result in unanticipated costs or dilute our stockholders.
  • We may become subject to litigation, which could have a material adverse effect on our business, financial condition and results of operations.
  • Our operating results have in the past and may continue to fluctuate significantly and if we fail to meet the expectations of analysts or investors, our stock price and the value of your investment could decline substantially.
  • As a result of our variable sales and implementation cycles, we may be unable to recognize revenue to offset expenditures, which could result in fluctuations in our quarterly results of operations or otherwise harm our future operating results.
  • Certain of our operating results and financial metrics, including the key metrics included in this report, may be difficult to predict as a result of seasonality.
  • We have identified a material weakness in our internal control over financial reporting and may identify additional material weaknesses in the future or otherwise fail to maintain an effective system of internal controls, which may result in material misstatements of our financial statements or cause us to fail to meet our periodic reporting obligations.
  • We may be subject to additional tax liabilities in connection with our operations or due to future legislation, each of which could materially impact our financial position and results of operation.
  • Interruption or failure of our information technology and communications systems could impair our ability to effectively deliver our products and services, which could cause us to lose clients and harm our operating results.
  • Natural or man-made disasters and other similar events may significantly disrupt our business and negatively impact our business, financial condition and results of operations.
  • Business or economic disruptions or global health concerns have and may continue to seriously harm our business and increase our costs and expenses.
  • If our services fail to provide accurate and timely information, or if our content or any other element of our service is associated with errors or malfunctions, we could have liability to clients, providers or patients which could adversely affect our results of operations.
  • Our marketing efforts depend significantly on our ability to receive positive references from our existing clients.
  • Our payments platform is a core element of our business. If our payments platform is limited, restricted, curtailed or degraded in any way, or if we fail to continue to grow and develop our payments platform, our business may be materially and adversely affected.
  • Increases in card network fees and other changes to fee arrangements may result in the loss of clients who use our payment processing services or a reduction in our earnings.
  • If we fail to comply with the applicable requirements of card networks, they could seek to fine us, suspend us or terminate our payment facilitator status. If our clients or sales partners incur fines or penalties that we cannot collect from them, we may have to bear the cost of such fines or penalties.
  • Our business and growth strategy depend on our ability to maintain and expand a network of provider clients. If we are unable to do so, our future growth would be limited and our business, financial condition and results of operations would be harmed.
  • We may be liable for use of incorrect or incomplete data we provide which could harm our business, financial condition and results of operations.
  • Our services present the potential for embezzlement, identity theft or other similar illegal behavior by our employees or subcontractors with respect to third parties.
  • If we cannot maintain our corporate culture as we grow, we could lose the innovation, teamwork, passion and focus on execution that we believe contribute to our success, and our business may be harmed.
  • Any failure to offer high-quality client support services could adversely affect our relationships with our clients and strategic partners and our operating results.
  • Our ability to limit our liabilities by contract or through insurance may be ineffective or insufficient to cover our future liabilities.
  • Changes in laws and regulations relating to interchange fees on payment card transactions would adversely affect our revenue and results of operations.
  • Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations.
  • Economic uncertainties or downturns in the general economy or the industries in which our clients operate could disproportionately affect the demand for our solution and negatively impact our results of operations.
  • If we or our clients fail to comply with federal and state laws governing submission of false or fraudulent claims to government healthcare programs and financial relationships among healthcare providers, we or our clients may be subject to civil and criminal penalties or loss of eligibility to participate in government healthcare programs.
  • The U.S. Food and Drug Administration may in the future determine that our technology solutions are subject to the Federal Food, Drug, and Cosmetic Act and we may face additional costs and risks as a result.
  • Potential additional regulation of the disclosure of health information outside the United States may adversely affect our operations and may increase our costs.
  • Individuals may claim our text messaging services are not compliant with the Telephone Consumer Protection Act.
  • Our risk management policies and procedures may not be fully effective in mitigating our risk exposure in all market environments or against all types of risk.
  • Our office in Ottawa, Canada is subject to the laws and regulations of the government of Canada and its subdivisions.
  • Changes in accounting rules, assumptions and/or judgments could materially and adversely affect us.
  • In order to support the growth of our business, we may need to incur additional indebtedness under our current credit facilities or seek capital through new equity or debt financings, which sources of additional capital may not be available to us on acceptable terms or at all.
  • Restrictive covenants in the agreements governing our credit facility may restrict our ability to pursue our business strategies.
  • Despite our outstanding indebtedness, we may still be able to incur substantially more debt. This could further exacerbate the risks associated with our substantial leverage.
  • Our share price may be volatile, and you could lose all or part of your investment.
  • If a substantial number of shares become available for sale and are sold in a short period of time, the market price of our common stock could decline.
  • Anti-takeover provisions under our incorporation documents and Delaware law could delay or prevent a change of control which could limit the market price of our common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management.
  • Our bylaws designate certain specified courts as the sole and exclusive forums for certain disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.
  • We do not currently intend to pay dividends on our common stock and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.
  • We are an emerging growth company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our common stock less attractive to investors.
  • We could be subject to securities class action litigation.
  • We are subject to increased costs as a result of operating as a public company, and our management will devote substantial time to new compliance initiatives.
  • An active public market may not develop or be sustained.
Management Discussion
  • •Total revenue increased 25% to $124.8 million in fiscal 2020, compared with $99.9 million in fiscal 2019.
  • •Net loss was $20.3 million in fiscal 2020, compared with $15.1 million in fiscal 2019.
  • •Adjusted EBITDA was positive $4.8 million in fiscal 2020, compared with positive $3.5 million in fiscal 2019.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Good